Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £150.67. The company’s shares opened today at p12,134.00.

1,153,041.68 AMD per troy ounce 07/03/2025 Gold (LBMA,AZN,PM) 4,967.74 AZN per troy ounce 07/03/2025 Gold (LBMA,BYN,PM) 9,451.86 BYN per troy ounce 07/03/2025 Gold (LBMA,CNY,PM) 20,953.64 CNY per troy ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

In a report released on February 24, Florent Cespedes from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of p11,772.00. The company’s shares ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

After hours: 17 March at 7:53:12 pm GMT-4 Loading Chart for AZN ...

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...